跳轉至內容
Merck
全部照片(1)

重要文件

查看所有文件

S-018

Supelco

舒芬太尼-D5标准液 溶液

100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

登入查看組織和合約定價
全部照片(1)

About This Item

經驗公式（希爾表示法）:
C22D5H25N2O2S
CAS號碼:
1884682-16-9
分子量：:
391.58
EC號碼:
200-659-6
分類程式碼代碼:
41116107
NACRES:
NA.24

等級

certified reference material

品質等級

300

形狀

liquid

特點

Snap-N-Spike®/Snap-N-Shoot®

包裝

ampule of 1 mL

製造商／商標名

Cerilliant®

drug control

Narcotic Licence Schedule A (Switzerland); estupefaciente (Spain); Decreto Lei 15/93: Tabela IA (Portugal)

濃度

100 μg/mL in methanol

技術

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

應用

forensics and toxicology

形式

single component solution

儲存溫度

2-8°C

SMILES 字串

[2H]C([2H])(C)C(=O)N(c1ccccc1)C2(CCN(CCc3cccs3)CC2)COC

InChI

1S/C22H30N2O2S/c1-3-21(25)24(19-8-5-4-6-9-19)22(18-26-2)12-15-23(16-13-22)14-11-20-10-7-17-27-20/h4-10,17H,3,11-16,18H2,1-2H3/i3D2

InChI 密鑰

GGCSSNBKKAUURC-SMZGMGDZSA-N

相關類別

一般說明

Sufentanil is a short acting synthetic opioid analgesic used as a painkiller during medical operations. This stable-labeled internal standard is suitable for quantitation of sufentanil levels in urine, serum, or plasma by LC/MS or GC/MS for clinical toxicology, pain prescription monitoring, forensic analysis, or isotope dilution methods. Sufentanil is sold under the trade name Sufenta.

法律資訊

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

相關產品

產品號碼
描述
訂價

A-071

阿芬太尼标准液 盐酸盐 溶液, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

P-071

13种疼痛管理混标 溶液, 100 μg/mL each component (10 μg/mL Fentanyl), ampule of 1.0 mL, certified reference material, Cerilliant®

F-001

芬太尼-D5标准液 CRM 溶液, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

F-002

芬太尼标准液 溶液, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

F-013

芬太尼标准液 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

N-030

去甲芬太尼-D5标准液 CRM 草酸酯 溶液, 100 μg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

N-031

去甲芬太尼标准液 草酸酯 溶液, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

N-055

去甲芬太尼-D5标准液 CRM 草酸酯 溶液, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

S-008

舒芬太尼标准液 溶液, 100 μg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

B-066

丁酰芬太尼标准液 溶液, 100 μg/mL in methanol, certified reference material, ampule of 0.5 mL, Cerilliant®

C-162

卡芬太尼标准液 溶液, (sold as 100 ug/mL in methanol as free base), certified reference material, ampule of 0.5 mL, Cerilliant®

C-163

卡芬太尼-D5标准液 溶液, 100 μg/mL in methanol (as free base), certified reference material, ampule of 0.5 mL, Cerilliant®

M-194

(±)-顺-3-甲基芬太尼盐酸盐标准液 盐酸盐 溶液, 100 μg/mL in methanol (as free base), certified reference material, ampule of 0.5 mL, Cerilliant®

A-139

4-ANPP标准液 溶液, 100 μg/mL in methanol, certified reference material, ampule of 0.5 mL, Cerilliant®

F-049

全氟芬太尼标准液 溶液, 100 μg/mL in methanol, certified reference material, ampule of 0.5 mL, Cerilliant®

I-038

异丁酰芬太尼标准液 盐酸盐 溶液, 100 μg/mL in methanol (as a free base), certified reference material, ampule of 0.5 mL, Cerilliant®

N-114

草酸去甲卡芬太尼 草酸盐 溶液, 100 μg/mL in methanol (as a free base), certified reference material, ampule of 0.5 mL, Cerilliant®

V-048

戊酰芬太尼标准液 盐酸盐 溶液, 100 μg/mL in methanol (as a free base), certified reference material, ampule of 0.5 mL, Cerilliant®

A-140

丙烯酰芬太尼 盐酸盐 溶液, 100 μg/mL in methanol (as free base), certified reference material, ampule of 0.5 mL, Cerilliant®

O-047

奥芬太尼标准液 溶液, 100 μg/mL in methanol, certified reference material, ampule of 0.5 mL, Cerilliant®

F-048

对全氟丁酰芬太尼(PFBF)标准液 溶液, 100 μg/mL in methanol (), certified reference material, ampule of 0.5 mL, Cerilliant®

H-130

β羟基硫代芬太尼标准液 盐酸盐 溶液, 100 μg/mL in methanol (as free base), certified reference material, ampule of 0.5 mL, Cerilliant®

D-168

N-去甲基U-47700-D3 溶液, 100 μg/mL in acetonitrile, certified reference material, ampule of 1 mL, Cerilliant®

D-167

N-去甲基U-47700 溶液, 1 mg/mL in acetonitrile, certified reference material, ampule of 1 mL, Cerilliant®

F-050

4-氟异丁酰芬太尼标准液 溶液, 100 μg/mL in methanol, certified reference material, ampule of 0.5 mL, Cerilliant®

A-157

4-ANPP-D5标准液 溶液, 100 μg/mL in methanol, certified reference material, ampule of 0.5 mL, Cerilliant®

F-054

邻全氟芬太尼标准液 盐酸盐 溶液, 100 μg/mL in methanol (as free base), certified reference material, ampule of 0.5 mL, Cerilliant®

M-200

甲氧乙酰芬太尼标准液 盐酸盐 溶液, 100 μg/mL in methanol (as free base), certified reference material, ampule of 0.5 mL, Cerilliant®

V-068

戊酰芬太尼-D5标准液 盐酸盐 溶液, 100 μg/mL in methanol (as free base), certified reference material, ampule of 0.5 mL, Cerilliant®

C-177

环丙芬太尼标准液 盐酸盐 溶液, 100 μg/mL in methanol (as free base), certified reference material, ampule of 0.5 mL, Cerilliant®

F-053

呋喃芬太尼-D5标准液 盐酸盐 溶液, 100 μg/mL in methanol (as free base), certified reference material, ampule of 0.5 mL, Cerilliant®

A-156

卡芬太尼-D5标准液 盐酸盐 溶液, 100 μg/mL in methanol (as free base), certified reference material, ampule of 0.5 mL, Cerilliant®

訊號詞

Danger

危險分類

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

標靶器官

Eyes

儲存類別代碼

3 - Flammable liquids

水污染物質分類（WGK）

WGK 1

閃點（°F）

49.5 °F - closed cup

閃點（°C）

9.7 °C - closed cup

從最近期的版本中選擇一個：

分析證明 (COA)

Lot/Batch Number

抱歉，我們目前沒有在線上提供本產品的COA

如果您需要協助，請聯絡 客戶支援

已經擁有該產品？

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Harold S Minkowitz et al.
Regional anesthesia and pain medicine, 38(2), 131-139 (2012-12-29)
A sublingual sufentanil tablet is being developed as a potential alternative to intravenous (IV) opioids for the management of postoperative pain. The objective of these studies was to evaluate the pharmacokinetics, efficacy, and safety of sublingual sufentanil tablets for postoperative
C Jeleazcov et al.
British journal of anaesthesia, 109(5), 698-706 (2012-07-27)
Target controlled infusion (TCI) with sufentanil is usually performed using the Gepts model, which was derived from patients undergoing general surgery. It is, however, known that pharmacokinetics of sufentanil can be changed during cardiopulmonary bypass (CPB). We tested whether TCI
Q L Chen et al.
Acta anaesthesiologica Scandinavica, 57(2), 236-242 (2012-08-14)
Sufentanil is widely used in clinical anaesthesia because of its protective effects against ischaemia/reperfusion injury. Diabetes mellitus elevates the activity of glycogen synthase kinase-3β (GSK-3β), thereby increasing the permeability of mitochondrial transition pore. This study investigated the role of GSK-3β
Shen Sun et al.
Journal of anesthesia, 27(1), 25-28 (2012-08-28)
We aimed to investigate the effects of pretreatment with a small dose of dexmedetomidine on the cough caused by sufentanil during anesthetic induction. Two hundred and forty patients undergoing elective gynecological surgery under general anesthesia were randomly allocated to 4
S Dango et al.
British journal of anaesthesia, 110(3), 443-449 (2012-11-16)
Although thoracic epidural analgesia (TEA) is considered the gold standard for post-thoracotomy pain relief, thoracic paravertebral block (PVB) and intrathecal opioid (ITO) administration have also been shown to be efficacious. We hypothesized that the combination of PVB and ITO provides
查看所有相關論文

我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務